Permissive Hypercapnia Results in Decreased Functional Vessel Density in the Skin of Extremely Low Birth Weight Infants by Puchwein-Schwepcke, Alexandra Francoise et al.
March 2018 | Volume 6 | Article 521
CliniCal Trial
published: 13 March 2018
doi: 10.3389/fped.2018.00052
Frontiers in Pediatrics | www.frontiersin.org
Edited by: 
Eugene Dempsey, 
University College Cork, Ireland
Reviewed by: 
Gerhard Pichler, 
Medizinische Universität Graz, Austria 
Kai König, 
Medicum Wesemlin, Switzerland
*Correspondence:
Alexandra Francoise Puchwein-
Schwepcke  
alexandra.schwepcke@ 
med.uni-muenchen.de
Specialty section: 
This article was submitted to 
Neonatology, 
a section of the journal 
Frontiers in Pediatrics
Received: 23 December 2017
Accepted: 23 February 2018
Published: 13 March 2018
Citation: 
Puchwein-Schwepcke AF, 
Schottmayer K, Mormanová Z, 
Dreyhaupt J, Genzel-Boroviczeny O 
and Thome UH (2018) Permissive 
Hypercapnia Results in Decreased 
Functional Vessel Density in 
the Skin of Extremely Low 
Birth Weight Infants. 
Front. Pediatr. 6:52. 
doi: 10.3389/fped.2018.00052
Permissive Hypercapnia results in 
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Jens Dreyhaupt2, Orsolya Genzel-Boroviczeny1 and Ulrich H. Thome3
1 Divsion of Neonatology, Dr. von Hauner Children’s Hospital, Ludwig-Maximilians-University, Munich, Germany, 2 Institute for 
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Background: Ventilator-induced lung injury with subsequent bronchopulmonary 
dysplasia remains an important issue in the care of extremely low-birth-weight infants. 
Permissive hypercapnia has been proposed to reduce lung injury. Hypercapnia changes 
cerebral perfusion, but its influence on the peripheral microcirculation is unknown.
Methods: Data were collected from 12 infants, who were randomized to a permissive 
high PCO2 target group (HTG) or a control group (CG). Inclusion criteria were birth weight 
between 400 and 1,000 g, gestational age from 23 to 28 6/7 weeks, intubation during 
the first 24 h of life, and no malformations. The PCO2 target range was increased step-
wise in both groups for weaning and was always 15 mmHg higher in the HTG than in the 
CG. Skin microvascular parameters were assessed non-invasively with sidestream dark 
field imaging on the inner side of the right arm every 24 h during the first week of life and 
on the 14th day of life.
results: Infants in the HTG had significantly higher max. PCO2 exposure, which was 
associated with a significantly and progressively reduced functional vessel density (FVD, 
p < 0.01). Moreover, there were significant differences in the diameter distribution over 
time, with HTG subjects having fewer small vessels but more large vessels.
Conclusion: High PCO2 levels significantly impaired peripheral microcirculation in 
preterm infants, as shown by a decreased FVD, presumably secondary to peripheral 
vasoconstriction.
iSrCTn: 56143743.
Keywords: microcirculation, hypercapnia, extremely low birth weight infants, functional vessel density, skin 
perfusion
Abbreviations: A/C, assisted/controlled; AUC, area under the curve; BPD, bronchopulmonary dysplasia; ELBI, extremely 
low birth weight infant; SDF, sidestream dark field; FVD, functional vessel density; HTG, high PCO2 target group; HFO, 
high-frequency oscillation; HR, heart rate; IVH, intraventricular hemorrhage; MAP, mean airway pressure; CG, control group; 
OPS, orthogonal polarization spectral; PDA, persistent ductus arteriosus; PEEP, positive end-expiratory pressure; PIP, positive 
inspiratory pressure; SIMV, synchronized intermittent mandatory ventilation; VS, vessel surface.
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inTrODUCTiOn
Most extremely low-birth-weight infants (<1,000  g) require 
respiratory assistance after birth, leading to bronchopulmonary 
dysplasia (BPD), a chronic form of lung disease (1, 2). Permissive 
hypercapnia is a strategy of tolerating higher PCO2 levels for the 
benefit of less aggressive ventilation and therefore less mecha-
nical trauma to the lung (3–7). In randomized trials, ventilatory 
intensities were reduced but resulted in only marginal positive 
effects on clinical outcome (6, 8–11). Concerns about possible 
adverse effects such as intraventricular hemorrhage with con-
secutive developmental impairment, as suggested by retrospec-
tive data (12–15), have not been substantiated in randomized 
controlled trials (6, 8–11). We know that hypercapnia causes 
dilatation of cerebral arterioles with possibly increased risk of 
intracranial bleeding (16). On the level of the microcirculation, 
hypoxia and hypercapnia lead to an increase in perfusion in the 
cerebral cortex of the rat (17, 18).
In the past 10 years, we have learned that disturbances in the 
microcirculation have profound effects on outcome. In sepsis, 
for example, a persistent decrease in functional vessel density 
(FVD) is indicative of poor survival (19, 20). Changes in the 
microcirculation were also observed in many different settings 
such as subarachnoid hemorrhage, congenital heart disease, or 
myocardial ischemia (21–23). In the preterm infant, a persistent 
ductus arteriosus (PDA) significantly changes the microcircula-
tion of the skin (24). In preterm hypotensive newborns, FVD in 
the periphery was significantly elevated in comparison to normo-
tensive infants, suggesting a redistribution of microvascular flow 
as an underlying mechanism for hypotension (25).
Therefore, the microcirculation is an important, but under-
recognized physiologic function with possible impact on 
important clinical outcome parameters. Furthermore, the micro-
circulation may be influenced by PCO2. We sought to measure 
the microcirculation in very preterm infants participating in a 
multicenter randomized controlled trial of different PCO2 target 
ranges (PHELBI) (10). The skin of the preterm infants is a specific 
and easily accessible organ to observe changes in the microcircu-
lation. Our hypothesis was that the cutaneous microcirculation 
might be affected by higher PCO2 levels during permissive hyper-
capnia regarding FVD, diameter distribution, and quality of flow.
MaTErialS anD METHODS
This study was part of the randomized, prospective multicenter 
hypercapnia study (PHELBI, ISRCTN 56143743) (10). Infants 
with gestational ages between 23 and 28 6/7  weeks and birth 
weights between 400 and 1,000 g, who were intubated during the 
first 24 h, were randomized within the next 12 h to either a high 
PCO2 target group (HTG) or a control group (CG) after written 
parental consent. Exclusion criteria were congenital malforma-
tions, chromosomal aberrations, and severe asphyxia [pH < 7.0 
and heart rate (HR) < 100/min at 10 min of life]. All infants who 
participated in the PHELBI trial at our center within a predefined 
time frame of 18 months were included in this study.
During the first 14 days of life, the PCO2 target ranges were 
increased stepwise with the target range in the HTG always 
15 mmHg higher than in the CG. PCO2 levels were kept between 
55 and 65  mmHg in the HTG and 40 and 50  mmHg in the 
CG during the first 3  days, increased to 60–70  mmHg (HTG) 
and 45–55  mmHg (CG) on the fourth day, and increased to 
65–75 mmHg (HTG) and 50–60 mmHg (CG) again on the sev-
enth day until extubation or peak inspiratory pressure <12 cm 
H2O or day 14. At our center, the skin microcirculation of a 
subgroup of randomized infants was evaluated as single-center 
substudy. The institutional review board of the Medical Faculty 
of Ludwig Maximilians University of Munich approved the study 
protocol and the consent forms, and all parents granted written 
informed consent.
Sidestream dark field (SDF) imaging with the handheld video 
microscope “MicroScan” (Microvision Medical, Wallingford, 
Pennsylvania) with a five times magnification was used for the 
assessment of the microcirculation. Monochromatic green 
light (530  nm) emitted from LEDs, surrounding a light guide, 
is absorbed by hemoglobin in the erythrocytes and reflected 
by other tissues or structures. The result is a real-time video of 
perfused vessels to a depth of 3 mm, thus producing a functional 
video of the microcirculation. SDF imaging has been validated 
against conventional capillary microscopy in various studies 
(26–29). We obtained sequences of 15 s on three different areas 
on the right inner upper arm. The sublingual region usually 
preferred for SDF imaging in adults is not feasible in preterm 
infants. In previous studies, the upper arm has been shown to be 
easily accessible and to provide a good image quality (24, 25, 30, 
31). To reduce artifacts by lanugo hair, we chose the inner side of 
the arm. Since a PDA influences the skin microcirculation, we 
consistently used only the right arm to avoid the effects of PDA 
as a confounder (24).
Measurements started on the first day of life and continued 
over the first week in 24-h intervals, and the last measurement 
was obtained on the fourteenth day of life. All measurements 
were done by one investigator (KS). All video loops were ana-
lyzed offline with the microvision analysis software, which offers 
a semiautomatic analysis. Vessels are automatically detected on 
the screen, but individual corrections for artifacts such as hair are 
possible. FVD, which represents total vessel length in millimeter 
per image area in square millimeter, as well as the distribution of 
vessel diameters is subsequently calculated. The latter results in 
the representation of small (<10 μm), medium (10–20 µm), and 
large (20–100 µm) vessels as a percentage of the total vessel length. 
Moreover, quality of flow was analyzed, classifying vessels of a 
quadrant into vessels with “no flow,” “intermittent flow,” “sluggish 
flow,” “continuous flow,” and “hyperdynamic flow.” Normal flow is 
defined as continuous flow and hyperdynamic flow as extremely 
fast flow. No flow and intermittent and sluggish flow stand for 
different stages of hypodynamic and thus pathological flow. Flow 
classification was undertaken on the third, fourth, sixth, seventh, 
and fourteenth day of life and expressed as percentage of ves-
sels with the respective quality of flow. All video analyses were 
performed with the investigator blinded to patient, treatment, 
and time point.
Simple statistical analyses were performed with GraphPadPrism 
5 (GraphPad Software Inc., La Jolla, CA, USA). For each time 
point, three video scans per arm were analyzed, and the mean 
FigUrE 1 | A total number of 12 patients could be included to the study as illustrated in the Consort flow diagram.
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value of a variable was used for statistical analysis. To compare 
both groups over time, we used linear mixed effects regression 
models to account for the dependencies of measurements within 
each infant (fitted with proc mixed, SAS software version 9.4, SAS 
Institute, Cary, NC, USA). Group comparisons for categorical 
variables were performed using the chi-square test or Fisher’s 
exact test as appropriate.
For unpaired comparisons between the two groups, the 
Mann–Whitney U test was used for non-parametric data. For 
paired comparisons, the Wilcoxon signed-rank test was used.
To consider the development of PCO2 exposure between both 
groups, a further linear mixed effects regression model was used. 
For other laboratory values (hematocrit, lactate, and CRP), we 
compared minimal and maximal values over the observation 
period with the Mann–Whitney U test. Because of the exploratory 
nature of our study, the results of the statistical tests should not be 
interpreted as confirmatory. An adjustment for multiple testing 
was not done. p < 0.05 was considered as statistically significant.
The PCO2 levels were monitored by blood gas analyses, using 
arterial blood if available, or capillary blood. CRP levels, hemo-
globin levels, medication, and blood transfusions were extracted 
from the charts. Vital signs were recorded before the start of each 
microcirculation measurement.
rESUlTS
Clinical Variables
Twelve preterm infants were enrolled in our study (six from each 
randomization group, see Figure 1). Gender and birth weight dis-
tribution and other variables were similar (Table 1). One infant 
of the HTG group had to be excluded, as it was extubated on day 
2 of life. Another infant of the HTG group died on day 4 of life. 
Microcirculatory and clinical values of this infant were included 
as available. Ventilation parameters such as mean airway pres-
sure, positive end-expiratory pressure (PEEP), positive inspira-
tory pressure (PIP), high-frequency oscillation amplitude, and 
frequency tended to be lower in the HTG group, as expected, but 
not significantly. PCO2 values were significantly higher (Figure 2; 
Table  1). Incubator temperature and humidity, HR, and blood 
pressure did not differ. Other laboratory values, including hemo-
globin, hematocrit, lactate, and CRP, did not differ significantly.
Microcirculatory Variables
Images showed similar vasculature at baseline, but declining ves-
sel density toward the end of the study in the HTG (Figure 3). 
Similar results were determined by the quantitative evaluation.
TaBlE 1 | Clinical data.
High PCO2 target 
group (n = 5)
Control group  
(n = 6)
p Value
Gestational age (weeks)a 24 2/7  
(23 3/7–27 6/7)
25 4/7 (24 3/ 
7–27 2/7)
n.s.
Birth weight (g)a 685 (590–990) 712 (490–885) n.s.
Male gender 3 (60%) 3 (50%) n.s.
Betamethasone 5 (100%) 6 (100%) n.s.
Tracheal ventilation on day 14 3 (75%) 6 (100%) n.s.
Average PCO2 expositionb 56 (53–63) 51 (48–54) 0.03
Catecholamine treatment 1 (20%) 4 (80%) n.s.
Min. Hct% 31 (29–35) 30 (28–39) n.s.
Max. lactate (mmol/l) 2.6 (1.3–11.6) 3.2 (1.7–5.8) n.s.
Max. CRP (mg/l) 0.7 (0.3–3.8) 2.3 (0.2–8.2) n.s.
aMedian (minimum–maximum), Mann–Whitney U test.
bMedian (minimum–maximum), Wilcoxon rank sum test.
All others: n (%), Fisher’s exact test.
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FigUrE 2 | PCO2 minima and maxima in the high PCO2 target group (HTG) and control group (CG) over the course of 14 days after birth. Minimum and maximum 
values of all patients are presented as mean values with SDs. PCO2 target levels were stepwise increased on the fourth and seventh day of life. As intended, PCO2 
levels were higher in the HTG.
Functional Vessel Density
Functional vessel density did not differ at baseline between HTG 
and CG, but decreased significantly over the first week in the 
HTG and remained lower until the end of the study (Figure 4), 
compared to CG. The comparison between groups and the time 
effect was significant (both p <  0.01). Vessel surface (VS) was 
also significantly lower in the HTG group over time (Figure 5, 
p < 0.01 for the between-group comparison and p < 0.01 for the 
time effect).
Diameter
Most detected vessels were small with diameters <10  µm and 
varied between 60 and 80% of vessel density with no significant 
difference between the groups at baseline. In the HTG group, the 
proportion of small vessels significantly decreased (Figure  6), 
and therefore, the proportion of medium and large vessels 
increased significantly over time (Figure  7). This resulted in a 
significant difference between groups in the vessel distribution 
(p < 0.01) with a significant time effect (p < 0.05).
Flow
The flow in most vessels was continuous, and only a small 
fraction <6% had no flow in both groups. There were no sig-
nificant differences between both groups over the time observed. 
The stepwise increases of PCO2 targets on days 4 and 7 were not 
consistently followed by temporary increases of flow to hyperdy-
namic levels in all patients (data not shown).
DiSCUSSiOn
This study demonstrates that 14 days of permissive hypercapnia 
with relatively high PCO2 targets as used in this study have a 
significant impact on the microcirculation of the skin, compared 
to the CG with only mildly elevated targets. We demonstrated a 
significant decrease in FVD, whereas FVD remained constant in 
the CG. Thus, hypercapnia significantly reduced skin perfusion. 
The decrease is more prominent in the second week of permissive 
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FigUrE 3 | Typical image of the microcirculation. (a) Day 1 control group, 
(B) day 14 control group, (C) day 1 high PCO2 target group, and (D) day 14 
high PCO2 target group.
FigUrE 4 | Functional vessel density (FVD) over the course of 14 days. Mean and SD are shown. Overall, FVD was significantly lower in the high PCO2 target group 
(p < 0.01 by a linear mixed effects regression model) and time dependent (p < 0.01).
hypercapnia. This suggests a long-term influence of higher PCO2 
levels on skin capillaries. This is the first study to evaluate the 
influence of hypercapnia on the microcirculation of preterm 
infants over a longer time period (16–18, 32–43). Moreover, we 
demonstrate significant changes in the diameter distribution 
with a shift toward larger vessels in the HTG group. At the same 
time, other clinical parameters as well as ventilation parameters 
such as PIP and PEEP did not differ between both groups. Thus, 
the only difference between both groups relevant for our meas-
urements can be seen in the partial pressure of arterial CO2.
Peripheral oxygenation is essential for preserving organ 
function (44). Macrocirculatory parameters are only a poor 
indicator for tissue oxygen delivery (19). SDF imaging provides a 
non-invasive technique to visualize peripheral vasoregulation by 
using a microscope at the bedside.
The reduction of FVD and VS may be the result of a PCO2-
dependent redistribution of blood flow. Respiratory-induced 
changes in the partial pressure of arterial CO2 also play a major 
role in the regulation of cerebral blood flow (45). Hypercapnia 
leads to vasodilatation of cerebral arterioles, whereas hypocapnia 
leads to vasoconstriction and a subsequent decrease in cerebral 
arterial flow (46). Therefore, one would have expected a higher 
FVD in the HTG group, but the opposite effect was found. One 
possible explanation may be concurrent hypercapnia-induced 
vasodilatation in deeper areas of the body, including, but not 
limited, the brain, which may have drawn blood supply away 
from the skin, leading to a compensatory vasoconstriction and 
thus explaining the effects observed in this study.
Alternatively, high PCO2 may have a direct negative effect 
on skin perfusion. Both suggested mechanisms would lead to a 
redistribution of the blood volume toward larger vessels in the 
deeper areas.
Another possible explanation for a reduction in FVD and VS 
may be the so-called Bohr effect. Raised PCO2 levels and a low pH 
reduce the oxygen affinity of hemoglobin and facilitate oxygen 
unloading, thus enhancing oxygen diffusion from hemoglobin to 
the tissues (32, 34). Therefore, the lower FVD does not need to be 
a negative effect; it could also be a sign of better tissue oxygena-
tion while reducing the need for perfused blood vessels.
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FigUrE 5 | Vessel surface (VS) over the course of 14 days. Mean and SD are shown. Overall, VS was significantly lower in the high PCO2 target group (p < 0.01 for 
the between groups comparison, p < 0.01 for the time effect).
FigUrE 6 | Distribution of small vessels over the course of 14 days. Mean and SD are shown. In the high PCO2 target group, the proportion of small vessels 
significantly decreased resulting in a significant difference between groups in the vessel distribution (p < 0.01).
A fourth possible explanation for the reduction in FVD may 
be vasodilation due to high PCO2 values, which could explain the 
larger proportion of medium and large vessels observed in our 
HTG group. As a compensatory mechanism, small vessels would 
constrict and would result in a reduced overall FVD and VS due 
to hypercapnia.
Therefore, the significant changes in diameter distribution 
seem to be another interesting finding in our study. After birth, 
both groups showed a similar distribution of vessel diameter. 
When analyzed on the fourteenth day, the fraction of small vessels 
had decreased in the HTG, while it increased in the CG. In return, 
medium and large vessels were more prominent in the HT group.
Komori et  al. (36) described proportionate increasing 
diameters and velocity while increasing PCO2 up to levels of 
80 mmHg in rabbits. Hudetz et al. (18) obtained similar results 
when studying the effects of hypercapnia in the capillaries of 
the rat cerebral cortex. The increasing diameters are consistent 
with our observation that the proportion of medium and large 
vessels increases with higher PCO2 levels. However, we cannot 
confirm the increased velocity, because even though the fraction 
of hyperdynamic flow appeared to increase with higher PCO2 
targets, this did not reach statistical significance in our study. 
In sepsis models, similar microcirculatory changes indicated a 
poorer outcome (47, 48).
Due to the strict exclusion criteria and the very time-consuming 
methods and analyses, our study population was rather small and 
random errors cannot be ruled out. Another limitation might be 
that analyses of the flow were performed semiquantitatively.
The microcirculation is influenced by various factors, such 
as hematocrit and hemoglobin level, incubator temperature, 
blood transfusions, infections, PDA, and gender (16, 18, 24, 28, 
31, 49–52). There were no significant differences in our groups 
concerning these possible confounders. Blood pressure and 
HR showed no significant or only individual influence on the 
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FigUrE 7 | Distribution of medium and large vessels over the course of 14 days. Mean and SD are shown. In the high PCO2 target group (HTG), the proportion of 
medium and large vessels significantly increased over time (p < 0.05), resulting in a significant difference between groups in the vessel distribution (p < 0.01).
microcirculation in previous studies (30, 53) and were similar 
in both groups. Catecholamine treatment has been shown to 
increase FVD in premature infants (25), which might be a possible 
confounder in our results. Catecholamine treatment appeared to 
occur more frequently in the CG than the HTG, although this has 
not been statistically significant. However, catecholamines were 
given only for a few days. Effects of catecholamine treatment on the 
microcirculation have been demonstrated only in the first 6 h after 
birth and not after discontinuation of the treatment. Therefore, 
we do not think that catecholamine treatment confounded our 
results, showing long-term reduction in FVD seen in the HTG.
Another possible limitation is the lack of measurements 
between the seventh and the fourteenth day. We had decided 
beforehand to concentrate on the immediate effects after eleva-
tion of PCO2 as well as the long-term effects under treatment with 
permissive hypercapnia and not to focus on single data points.
Vascular development is a key process in lung development, 
and impaired vascular development has been linked to the emer-
gence of BPD. Due to our small patient group, we were unable to 
detect significant differences in clinical outcome. However, if we 
look at the missing benefit or even worsened pulmonary outcome 
of the patients of the HTG group in the PHELBI trial (10), we 
speculate that the pulmonary outcome may have been linked 
to the differences in microcirculation. If lung vessels respond 
in the same manner as skin vessels, the reduced vessel density 
after prolonged hypercapnia observed in this study may be one 
possible additional mechanism why permissive hypercapnia as 
performed in this study has not fulfilled the hope of reducing 
the incidence of BPD (10). Although flow was not significantly 
impaired in our study, which might be due to the small number of 
patients, a reduction in FVD results in a pronounced transforma-
tion of microvascular architecture, which could be an important 
pathophysiological mechanism in the genesis of BPD.
In conclusion, our study showed a significant decrease in FVD 
after long-term treatment with high PCO2 targets, possibly due 
to flow redistribution toward larger vessels in deeper areas. The 
microcirculation is a sensitive parameter that reacts to changes 
in multiple diseases or conditions. In our case, it provided a 
different perspective on the benefits and disadvantages reported 
under permissive hypercapnia (9) and should be further explored 
in larger studies.
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